arrow
H

Hui Wang

Chinese Academy of Sciences
H指数:35
被引数:7,380

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatic artery infusion chemotherapy (HAIC) combined with camrelizumab and apatinib as conversion therapy for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial

肝动脉灌注化疗(HAIC)联合卡瑞利珠单抗和阿帕替尼作为初始不可切除肝癌(HCC)转化治疗:一项前瞻性、单臂II期临床试验

2024-12-010
PRE